Empfehlung
13,0
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
52.1
1 Insider, 14,4M $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Bicara Therapeutics Inc. |
|---|---|
| Ticker | BCAX |
| CIK | 0002023658 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Bicara Therapeutics Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:36:21.508238 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -1,596 | 18.95 | -30,246.27 | -5,5% | |
| 2026-03-19 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -6,905 | 18.78 | -129,704.90 | -23,5% | |
| 2026-03-18 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -6,499 | 18.84 | -122,414.51 | -22,2% | |
| 2026-03-09 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -36,766 | 19.17 | -704,657.16 | -127,7% | |
| 2026-03-06 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -3,817 | 18.75 | -71,571.80 | -13,0% | |
| 2026-03-05 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -1,786 | 18.74 | -33,464.10 | -6,1% | |
| 2026-03-04 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -2,631 | 18.73 | -49,288.63 | -8,9% | |
| 2026-02-26 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 300,000 | 16.00 | 4,800,000.00 | +870,1% | |
| 2026-02-26 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 300,000 | 16.00 | 4,800,000.00 | +870,1% | |
| 2026-02-26 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Open Market Purchase | 300,000 | 16.00 | 4,800,000.00 | +870,1% | |
| 2025-12-22 | Hyep Ivan | Officer, Chief Financial Officer | Open Market Sale | -9,200 | 18.31 | -168,491.56 | -30,5% | |
| 2025-12-15 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -8,000 | 18.68 | -149,470.40 | -27,1% | |
| 2025-12-15 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -4,500 | 18.68 | -84,077.10 | -15,2% | |
| 2025-11-25 | Raben David | Officer, Chief Medical Officer | Open Market Sale | -906 | 18.84 | -17,071.21 | -3,1% | |
| 2025-11-25 | Raben David | Officer, Chief Medical Officer | Open Market Sale | -4,594 | 18.84 | -86,561.99 | -15,7% | |
| 2025-11-24 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -41,163 | 18.86 | -776,428.85 | -140,7% | |
| 2025-11-24 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -41,163 | 18.86 | -776,428.85 | -140,7% | |
| 2025-11-24 | Raben David | Officer, Chief Medical Officer | Open Market Sale | -5,500 | 18.45 | -101,475.00 | -18,4% | |
| 2025-11-24 | Hyep Ivan | Officer, Chief Financial Officer | Open Market Sale | -17,795 | 18.55 | -330,093.69 | -59,8% | |
| 2025-11-21 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -8,000 | 18.05 | -144,376.00 | -26,2% | |
| 2025-11-21 | Hyep Ivan | Officer, Chief Financial Officer | Open Market Sale | -605 | 18.15 | -10,980.75 | -2,0% | |
| 2025-11-21 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -4,500 | 18.05 | -81,211.50 | -14,7% | |
| 2025-10-16 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -24,103 | 18.83 | -453,760.67 | -82,3% | |
| 2025-10-16 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -24,103 | 18.83 | -453,760.67 | -82,3% | |
| 2025-10-15 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -4,500 | 18.16 | -81,699.30 | -14,8% | |
| 2025-10-15 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -8,000 | 18.16 | -145,243.20 | -26,3% | |
| 2025-10-15 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -13,289 | 18.84 | -250,391.34 | -45,4% | |
| 2025-10-15 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -13,289 | 18.84 | -250,391.34 | -45,4% | |
| 2025-10-13 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -11,445 | 18.92 | -216,545.12 | -39,3% | |
| 2025-10-13 | Mazumdar Claire | Director, Officer, Chief Executive Officer | Open Market Sale | -11,445 | 18.92 | -216,545.12 | -39,3% | |
| 2025-10-09 | Raben David | Officer, Chief Medical Officer | Open Market Sale | -22,000 | 18.45 | -405,900.00 | -73,6% | |
| 2025-10-09 | Hyep Ivan | Officer, Chief Financial Officer | Open Market Sale | -6,415 | 18.23 | -116,931.34 | -21,2% | |
| 2025-10-08 | Hyep Ivan | Officer, Chief Financial Officer | Open Market Sale | -5,627 | 18.21 | -102,456.42 | -18,6% | |
| 2025-10-07 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -8,000 | 18.06 | -144,472.80 | -26,2% | |
| 2025-10-07 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -2,900 | 18.06 | -52,371.39 | -9,5% | |
| 2025-10-07 | Hyep Ivan | Officer, Chief Financial Officer | Open Market Sale | -18,244 | 18.22 | -332,385.61 | -60,3% | |
| 2025-10-06 | Hyep Ivan | Officer, Chief Financial Officer | Open Market Sale | -6,514 | 18.17 | -118,356.12 | -21,5% | |
| 2025-10-06 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -15,600 | 18.06 | -281,665.80 | -51,1% | |
| 2025-10-06 | Cohlhepp Ryan | Director, Officer, President and COO | Open Market Sale | -24,000 | 18.06 | -433,332.00 | -78,6% | |
| 2025-09-29 | Meisner Lara | Officer, Chief Legal Officer | Open Market Sale | -33,807 | 14.75 | -498,653.25 | -90,4% | |
| 2025-09-15 | Meisner Lara | Officer, Chief Legal Officer | Open Market Sale | -15,829 | 11.49 | -181,875.21 | -33,0% | |
| 2025-06-16 | Meisner Lara | Officer, Chief Legal Officer | Open Market Sale | -15,829 | 10.43 | -165,096.47 | -29,9% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.